Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives
Hye-Yeong Jo(Seoul National University), Jung‐Hyun Kim(Korea National Institute of Health), Glyn Stacey(Institute of Zoology), Soo Kyung Koo(Korea National Institute of Health), Sung‐Hwan Moon(Kyungpook National University), Ji Hyeon Ju(St. Mary's Hospital), Han‐Jin Park(Korea Institute of Toxicology), Sun Kim(Seoul National University of Science and Technology), Hyemin Kim(Pohang University of Science and Technology), Mi‐Hyun Park(Korea National Institute of Health), Soon‐Jung Park(Konkuk University), Inuk Jung(Seoul National University), Hyo‐Won Han(Korea National Institute of Health), Dongho Geum(Korea University Medical Center)
Cited by 39
Related Papers
SARS-CoV-2 and Stroke in a New York Healthcare System
|Stroke|2020|751
MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression
|Nucleic Acids Research|2009|168
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
|Genes & Development|2011|161
DeepFam: deep learning based alignment-free method for protein family modeling and prediction
|Bioinformatics|2018|145
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications
|Stem Cell Reports|2017|137